Moderna’s omicron-targeted booster shot, which became available in September, increased the levels of antibodies that block the BA.5 coronavirus subvariant.
Moderna’s omicron-targeted booster shot, which became available in September, increased the levels of antibodies that block the BA.5 coronavirus subvariant.